U.S. Urology Devices Market is expected to grow with the CAGR of 10.3% in the forecast period of 2022 to 2029. The years considered for study are as mentioned below.

Access Full Report @ https://www.databridgemarketresearch.com/reports/us-urology-devices-market

U.S. urology devices market is a highly consolidated market, which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.

The major players dealing in U.S. urology devices market are introducing strong range of products provider along with launching new products and adopting strategic initiative such as acquisition, agreement, business expansion, award and recognition into the market. This helped companies to maximize the sales with enhanced product portfolio.

For instance:

• In March 2021, Baxter received FDA clearance for the AK 98 Hemodialysis Machine. The FDA clearance received would result in enhanced safety and availability of the AK 98 Hemodialysis Machine in the dialysis centers of the U.S. and Europe region. It would provide the customers for choice of therapy and support
• In December 2020, Fresenius SE & Co. KGaA had enhanced the use of home dialysis products and services in the U.S. and Europe region. The product enhancement would increase the demand of home dialysis products and increase the product revenue

Fresenius SE & Co. KGaA is the dominating player in U.S. urology devices market. The other key players existing in the market are Baxter, BOSTON SCIENTIFIC CORPORATION, Cardinal Health, Intuitive Surgical, Richard Wolf GmbH., Siemens Healthcare GmbH, GENERAL ELECTRIC, BD, Stryker, CooperSurgical Inc., Dornier MedTech., KARL STORZ SE & Co. KG, Dale Medical Products, Inc., Med Pro Medical B.V., Medi Tech Devices Pvt. Ltd., Medtronic, Coloplast Corp, Medi-Globe GmbH, Nikkiso Co., Ltd., B. Braun Melsungen AG, Lumenis Be Ltd., Teleflex Incorporated, Olympus Corporation, Cook among others.

BAXTER

Baxter was founded in the year 1930 and is headquartered in Illinois, U.S. The company focuses on saving and sustaining lives and elevating patient care.

Company provide products via various product category such as critical care, hospital care, nutritional care, renal care, surgical care in which renal care is market focused.

For instance,

• In March, 2021, Baxter received FDA clearance for the AK 98 Hemodialysis Machine. The FDA clearance received would result in enhanced safety and availability of the AK 98 Hemodialysis Machine in the dialysis centers of the U.S. and Europe region. It would provide the customers for choice of therapy and support

The company has presence across Argentina, Australia, Brazil, Canada, China, Columbia, Germany, and India among others. The company has various subsidiaries including Baxter Corporation Englewood (U.S.), Baxter Healthcare Corporation (U.S.), Baxter Pharmaceutical Solutions LLC (U.S.), Baxter Healthcare Pty Ltd (Australia), Baxter Belgium SPRL (Belgium), Baxter Distribution Center Europe SA (Belgium), Baxter R and D Europe SPRL (Belgium), Baxter SA (Belgium) among others

FRESENIUS SE & CO. KGAA

Fresenius SE & Co. KGaA was founded in the year 1912 and is headquartered in Hesse, Germany. The company is a global healthcare group and focuses on offering high-quality products and services for dialysis, hospitals, and outpatient treatment.

Company provide products via various product category such as dialysis, apheresis, infusion therapy, clinical nutrition, transfusion technology, hospitals, health prevention and health tourism in which dialysis is market focused.

For instance,

• In December 2020, Fresenius SE & Co. KGaA had enhanced the use of home dialysis products and services in the U.S. and Europe region. The product enhancement would increase the demand of home dialysis products and increase the product revenue

The company has wide presence North America, Latin America, Africa, Europe, and Asia-Pacific. The company also has various subsidiary such as Fresenius Kabi (Germany), Helios Kliniken GmBh (Germany), Curalie GmBh(Germany), Vamed Engineering (Germany), Fresenius Helios GmBh (Germany), Fresenius Kabi NV (Germany) among others.

BOSTON SCIENTIFIC CORPORATION

BOSTON SCIENTIFIC CORPORATION was founded in the year 1979 and is headquartered in Massachusetts, U.S. The company focuses on development, manufacturing and marketing of medical devices by accelerating innovative medical solutions and research to improve patient lives.

Company provide products via various product category such as electrophysiology products, female pelvic medicine products, gastroenterology products, gastrointestinal surgery products, gynaecology products, interventional cardiology products, interventional radiology products, neurological surgical products, pain management products, pulmonary products, urology products and vascular surgery products in which urology products is market focused.

The company has presence across North America, Europe, and Asia-Pacific. The company also has various subsidiaries including Atritech NV/SA(Belgium), Asthmatx,Inc (Delaware),Boston Scientific Sdn.Bhd. (Malaysia), Boston Scientific Limited (South Africa), Boston Scientific Ltd.(Thailand),among others.